These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics. Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996 [TBL] [Abstract][Full Text] [Related]
8. Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy. Zhu H; Li J; Zhang XB; Ye M; Tan W ChemMedChem; 2015 Jan; 10(1):39-45. PubMed ID: 25277749 [TBL] [Abstract][Full Text] [Related]
9. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents. Kim M; Kim DM; Kim KS; Jung W; Kim DE Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327 [TBL] [Abstract][Full Text] [Related]
10. Advances in the development of aptamer drug conjugates for targeted drug delivery. Chen K; Liu B; Yu B; Zhong W; Lu Y; Zhang J; Liao J; Liu J; Pu Y; Qiu L; Zhang L; Liu H; Tan W Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 May; 9(3):. PubMed ID: 27800663 [TBL] [Abstract][Full Text] [Related]
11. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine. Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890 [TBL] [Abstract][Full Text] [Related]
12. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy. Li X; Zhao Q; Qiu L J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885 [TBL] [Abstract][Full Text] [Related]
14. SELEX methods on the road to protein targeting with nucleic acid aptamers. Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856 [TBL] [Abstract][Full Text] [Related]
15. Towards targeted cancer therapy: Aptamer or oncolytic virus? Tan KX; Danquah MK; Sidhu A; Ongkudon CM; Lau SY Eur J Pharm Sci; 2017 Jan; 96():8-19. PubMed ID: 27593990 [TBL] [Abstract][Full Text] [Related]
16. Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer. de Almeida CEB; Alves LN; Rocha HF; Cabral-Neto JB; Missailidis S Int J Pharm; 2017 Jun; 525(2):334-342. PubMed ID: 28373101 [TBL] [Abstract][Full Text] [Related]
17. Enhancing aptamer function and stability via in vitro selection using modified nucleic acids. Meek KN; Rangel AE; Heemstra JM Methods; 2016 Aug; 106():29-36. PubMed ID: 27012179 [TBL] [Abstract][Full Text] [Related]
18. Aptamers as drug delivery vehicles. Kruspe S; Mittelberger F; Szameit K; Hahn U ChemMedChem; 2014 Sep; 9(9):1998-2011. PubMed ID: 25130604 [TBL] [Abstract][Full Text] [Related]
19. [Advances in the study of aptamer-based drug for targeting therapy]. Dou XQ; Fu J; Song HF Yao Xue Xue Bao; 2016 Jul; 51(7):1068-76. PubMed ID: 29897179 [TBL] [Abstract][Full Text] [Related]
20. Application of aptamer functionalized nanomaterials in targeting therapeutics of typical tumors. Yin X; He Z; Ge W; Zhao Z Front Bioeng Biotechnol; 2023; 11():1092901. PubMed ID: 36873354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]